These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 7607408)

  • 1. Outer membrane permeability of beta-lactamase inhibitors in Pseudomonas aeruginosa.
    Satake S; Nakae T
    FEMS Microbiol Lett; 1995 Jun; 129(2-3):251-4. PubMed ID: 7607408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability to cefsulodin of the outer membrane of Pseudomonas aeruginosa and discrimination between beta-lactamase-mediated trapping and hydrolysis as mechanisms of resistance.
    Hewinson RG; Cartwright SJ; Slack MP; Whipp RD; Woodward MJ; Nichols WW
    Eur J Biochem; 1989 Feb; 179(3):667-75. PubMed ID: 2493375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that influence the permeability assay of the outer membrane of Pseudomonas aeruginosa.
    Lei Y; Satake S; Ishii J; Nakae T
    FEMS Microbiol Lett; 1991 May; 64(2-3):337-40. PubMed ID: 1909280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo bacterocodal interactions of clindamycin and ceftazidime, by non-beta-lactamase mechanisms, in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive beta-lactamase overproducing strain.
    Bayer AS; Lindsay P; Parr TR
    J Antimicrob Chemother; 1988 Oct; 22(4):529-39. PubMed ID: 3144525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.
    Nouda H; Harabe ET; Sumita Y; Okuda T; Fukasawa M
    Chemotherapy; 1992; 38(4):218-24. PubMed ID: 1473360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
    Michel-Briand Y; Nicolas T; Godard C; Plesiat P
    Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.
    Shapiro AB
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the Outer Membrane Protein OprD2 in Carbapenem-Resistance Mechanisms of Pseudomonas aeruginosa.
    Shen J; Pan Y; Fang Y
    PLoS One; 2015; 10(10):e0139995. PubMed ID: 26440806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the resistance mechanism via outer membrane protein OprD2 and metal β-lactamase expression in the cell wall of
    Cai S; Chen Y; Song D; Kong J; Wu Y; Lu H
    Exp Ther Med; 2016 Nov; 12(5):2869-2872. PubMed ID: 27882088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of biofilms on the production of beta-lactamases in Pseudomonas aeruginosa].
    Li Z; Jiang HD
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):613-6. PubMed ID: 19958682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of outer membrane proteins in imipenem diffusion in Pseudomonas aeruginosa.
    Lian Z; Tianjue Y
    Chin Med Sci J; 1999 Mar; 14(1):57-60. PubMed ID: 12899386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side chain SAR of bicyclic beta-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem.
    Blizzard TA; Chen H; Kim S; Wu J; Young K; Park YW; Ogawa A; Raghoobar S; Painter RE; Hairston N; Lee SH; Misura A; Felcetto T; Fitzgerald P; Sharma N; Lu J; Ha S; Hickey E; Hermes J; Hammond ML
    Bioorg Med Chem Lett; 2010 Feb; 20(3):918-21. PubMed ID: 20044254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overproduction of a metallo-beta-lactamase by a strong promoter causes high-level imipenem resistance in a clinical isolate of Pseudomonas aeruginosa.
    Takeda S; Nakai T; Ikeda F; Hatano K
    Chemotherapy; 2008; 54(3):181-7. PubMed ID: 18560224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.